Literature DB >> 7528329

Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids.

L Wu1, J H Bayle, B Elenbaas, N P Pavletich, A J Levine.   

Abstract

The carboxy-terminal domain of the p53 protein comprising amino acid residues 311 to 393 is able to promote the reassociation of single-stranded RNA or DNA into duplex hybrids. This domain is as efficient as the intact p53 protein in both the rate and the extent of the double-stranded product produced in this reaction. Both wild-type and mutant p53 proteins from cancerous cells carry out this reaction. The monoclonal antibody PAb421, which detects an epitope between residues 370 and 378, blocks the ability of p53 to reassociate single strands of RNA or DNA. Similarly, the alternative splice form of the murine p53 protein, which removes amino acid residues 364 to 390 and replaces them with 17 new amino acids, does not carry out the reassociation reaction with RNA or DNA. This is the first indication of functionally distinct properties of the alternative splice forms of p53. These results suggest that this splice alternative can regulate a p53-mediated reaction that may be related to the functions of this protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7528329      PMCID: PMC231999          DOI: 10.1128/MCB.15.1.497

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Monoclonal antibody analysis of p53 expression in normal and transformed cells.

Authors:  J W Yewdell; J V Gannon; D P Lane
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

2.  Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

Authors:  L Banks; G Matlashewski; L Crawford
Journal:  Eur J Biochem       Date:  1986-09-15

3.  Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule.

Authors:  D Wolf; N Harris; N Goldfinger; V Rotter
Journal:  Mol Cell Biol       Date:  1985-01       Impact factor: 4.272

4.  A new anti-p53 monoclonal antibody, previously reported to be directed against the large T antigen of simian virus 40.

Authors:  J Milner; A Cook; M Sheldon
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

5.  Monoclonal antibodies specific for simian virus 40 tumor antigens.

Authors:  E Harlow; L V Crawford; D C Pim; N M Williamson
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

6.  p53 and E2F-1 cooperate to mediate apoptosis.

Authors:  X Wu; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer.

Authors:  G Bakalkin; T Yakovleva; G Selivanova; K P Magnusson; L Szekely; E Kiseleva; G Klein; L Terenius; K G Wiman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

8.  Endogenous p53 protein generated from wild-type alternatively spliced p53 RNA in mouse epidermal cells.

Authors:  M F Kulesz-Martin; B Lisafeld; H Huang; N D Kisiel; L Lee
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

9.  Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.

Authors:  J Lin; J Chen; B Elenbaas; A J Levine
Journal:  Genes Dev       Date:  1994-05-15       Impact factor: 11.361

10.  Purification of complexes of nuclear oncogene p53 with rat and Escherichia coli heat shock proteins: in vitro dissociation of hsc70 and dnaK from murine p53 by ATP.

Authors:  C F Clarke; K Cheng; A B Frey; R Stein; P W Hinds; A J Levine
Journal:  Mol Cell Biol       Date:  1988-03       Impact factor: 4.272

View more
  36 in total

1.  Activation of p53 protein by telomeric (TTAGGG)n repeats.

Authors:  M Milyavsky; A Mimran; S Senderovich; I Zurer; N Erez; I Shats; N Goldfinger; I Cohen; V Rotter
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

2.  Interactions between p53, hMSH2-hMSH6 and HMG I(Y) on Holliday junctions and bulged bases.

Authors:  Deepa Subramanian; Jack D Griffith
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

3.  p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance.

Authors:  Zaineb R Abdul Razak; Robert J Varkonyi; Michelle Kulp-McEliece; Corrado Caslini; Joseph R Testa; Maureen E Murphy; Dominique Broccoli
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

4.  Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53.

Authors:  Y Wu; H Huang; Z Miner; M Kulesz-Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

5.  p53-mediated DNA renaturation can mimic strand exchange.

Authors:  D Jean; D Gendron; L Delbecchi; P Bourgaux
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

Review 6.  p53, a translational regulator: contribution to its tumour-suppressor activity.

Authors:  V Marcel; F Catez; J-J Diaz
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

7.  Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.

Authors:  Kasandra J-L Riley; Laura A Cassiday; Akash Kumar; L James Maher
Journal:  RNA       Date:  2006-04       Impact factor: 4.942

8.  Species- and tissue-specific expression of the C-terminal alternatively spliced form of the tumor suppressor p53.

Authors:  K Will; G Warnecke; S Bergmann; W Deppert
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

9.  p53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes.

Authors:  V A Tron; M J Trotter; L Tang; M Krajewska; J C Reed; V C Ho; G Li
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

10.  Adenovirus type 5 E4orf3 protein relieves p53 inhibition by E1B-55-kilodalton protein.

Authors:  C König; J Roth; M Dobbelstein
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.